Global and United States Acquired Hemophilia Treatment Market Report & Forecast 2023-2028

Report ID: 1823131 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Acquired Hemophilia Treatment Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Acquired Hemophilia Treatment Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Acquired Hemophilia Treatment Market Size for the Year 2017-2028
        1.2.2 Global Acquired Hemophilia Treatment Market Size for the Year 2017-2028
    1.3 Acquired Hemophilia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Acquired Hemophilia Treatment in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Acquired Hemophilia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Acquired Hemophilia Treatment Market Dynamics
        1.4.1 Acquired Hemophilia Treatment Industry Trends
        1.4.2 Acquired Hemophilia Treatment Market Drivers
        1.4.3 Acquired Hemophilia Treatment Market Challenges
        1.4.4 Acquired Hemophilia Treatment Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Acquired Hemophilia Treatment by Type
    2.1 Acquired Hemophilia Treatment Market Segment by Type
        2.1.1 Traditional Therapy
        2.1.2 Advanced Therapy
    2.2 Global Acquired Hemophilia Treatment Market Size by Type (2017, 2022 & 2028)
    2.3 Global Acquired Hemophilia Treatment Market Size by Type (2017-2028)
    2.4 United States Acquired Hemophilia Treatment Market Size by Type (2017, 2022 & 2028)
    2.5 United States Acquired Hemophilia Treatment Market Size by Type (2017-2028)
3 Acquired Hemophilia Treatment by Application
    3.1 Acquired Hemophilia Treatment Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinic
        3.1.3 Others
    3.2 Global Acquired Hemophilia Treatment Market Size by Application (2017, 2022 & 2028)
    3.3 Global Acquired Hemophilia Treatment Market Size by Application (2017-2028)
    3.4 United States Acquired Hemophilia Treatment Market Size by Application (2017, 2022 & 2028)
    3.5 United States Acquired Hemophilia Treatment Market Size by Application (2017-2028)
4 Global Acquired Hemophilia Treatment Competitor Landscape by Company
    4.1 Global Acquired Hemophilia Treatment Market Size by Company
        4.1.1 Top Global Acquired Hemophilia Treatment Companies Ranked by Revenue (2021)
        4.1.2 Global Acquired Hemophilia Treatment Revenue by Player (2017-2022)
    4.2 Global Acquired Hemophilia Treatment Concentration Ratio (CR)
        4.2.1 Acquired Hemophilia Treatment Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Acquired Hemophilia Treatment in 2021
        4.2.3 Global Acquired Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Acquired Hemophilia Treatment Headquarters, Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Acquired Hemophilia Treatment Headquarters and Area Served
        4.3.2 Global Acquired Hemophilia Treatment Companies Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Acquired Hemophilia Treatment Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Acquired Hemophilia Treatment Market Size by Company
        4.5.1 Top Acquired Hemophilia Treatment Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Acquired Hemophilia Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Acquired Hemophilia Treatment Market Size by Region
    5.1 Global Acquired Hemophilia Treatment Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Acquired Hemophilia Treatment Market Size by Region (2017-2028)
        5.2.1 Global Acquired Hemophilia Treatment Market Size by Region: 2017-2022
        5.2.2 Global Acquired Hemophilia Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Acquired Hemophilia Treatment Market Size YoY Growth 2017-2028
        6.1.2 North America Acquired Hemophilia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Acquired Hemophilia Treatment Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Acquired Hemophilia Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Acquired Hemophilia Treatment Market Size YoY Growth 2017-2028
        6.3.2 Europe Acquired Hemophilia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Acquired Hemophilia Treatment Market Size YoY Growth 2017-2028
        6.4.2 Latin America Acquired Hemophilia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Acquired Hemophilia Treatment Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Acquired Hemophilia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Baxalta, Inc.
        7.1.1 Baxalta, Inc. Company Details
        7.1.2 Baxalta, Inc. Business Overview
        7.1.3 Baxalta, Inc. Acquired Hemophilia Treatment Introduction
        7.1.4 Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2017-2022)
        7.1.5 Baxalta, Inc. Recent Development
    7.2 Baxter Healthcare Corporation
        7.2.1 Baxter Healthcare Corporation Company Details
        7.2.2 Baxter Healthcare Corporation Business Overview
        7.2.3 Baxter Healthcare Corporation Acquired Hemophilia Treatment Introduction
        7.2.4 Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2017-2022)
        7.2.5 Baxter Healthcare Corporation Recent Development
    7.3 Bristol-Myers Squibb
        7.3.1 Bristol-Myers Squibb Company Details
        7.3.2 Bristol-Myers Squibb Business Overview
        7.3.3 Bristol-Myers Squibb Acquired Hemophilia Treatment Introduction
        7.3.4 Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2017-2022)
        7.3.5 Bristol-Myers Squibb Recent Development
    7.4 Genentech, Inc.
        7.4.1 Genentech, Inc. Company Details
        7.4.2 Genentech, Inc. Business Overview
        7.4.3 Genentech, Inc. Acquired Hemophilia Treatment Introduction
        7.4.4 Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2017-2022)
        7.4.5 Genentech, Inc. Recent Development
    7.5 Novo Nordisk A/S
        7.5.1 Novo Nordisk A/S Company Details
        7.5.2 Novo Nordisk A/S Business Overview
        7.5.3 Novo Nordisk A/S Acquired Hemophilia Treatment Introduction
        7.5.4 Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2017-2022)
        7.5.5 Novo Nordisk A/S Recent Development
    7.6 Ferring B.V.
        7.6.1 Ferring B.V. Company Details
        7.6.2 Ferring B.V. Business Overview
        7.6.3 Ferring B.V. Acquired Hemophilia Treatment Introduction
        7.6.4 Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2017-2022)
        7.6.5 Ferring B.V. Recent Development
    7.7 Sanofi SA
        7.7.1 Sanofi SA Company Details
        7.7.2 Sanofi SA Business Overview
        7.7.3 Sanofi SA Acquired Hemophilia Treatment Introduction
        7.7.4 Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2017-2022)
        7.7.5 Sanofi SA Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Acquired Hemophilia Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Acquired Hemophilia Treatment Market Trends
    Table 3. Acquired Hemophilia Treatment Market Drivers
    Table 4. Acquired Hemophilia Treatment Market Challenges
    Table 5. Acquired Hemophilia Treatment Market Restraints
    Table 6. Global Acquired Hemophilia Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Acquired Hemophilia Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Acquired Hemophilia Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Acquired Hemophilia Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Acquired Hemophilia Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Acquired Hemophilia Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Acquired Hemophilia Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Acquired Hemophilia Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Acquired Hemophilia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Hemophilia Treatment as of 2021)
    Table 15. Top Players of Acquired Hemophilia Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Acquired Hemophilia Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Acquired Hemophilia Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Acquired Hemophilia Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Acquired Hemophilia Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Acquired Hemophilia Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Acquired Hemophilia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Acquired Hemophilia Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Acquired Hemophilia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Acquired Hemophilia Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Acquired Hemophilia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Acquired Hemophilia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Acquired Hemophilia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Baxalta, Inc. Company Details
    Table 31. Baxalta, Inc. Business Overview
    Table 32. Baxalta, Inc. Acquired Hemophilia Treatment Product
    Table 33. Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 34. Baxalta, Inc. Recent Development
    Table 35. Baxter Healthcare Corporation Company Details
    Table 36. Baxter Healthcare Corporation Business Overview
    Table 37. Baxter Healthcare Corporation Acquired Hemophilia Treatment Product
    Table 38. Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 39. Baxter Healthcare Corporation Recent Development
    Table 40. Bristol-Myers Squibb Company Details
    Table 41. Bristol-Myers Squibb Business Overview
    Table 42. Bristol-Myers Squibb Acquired Hemophilia Treatment Product
    Table 43. Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 44. Bristol-Myers Squibb Recent Development
    Table 45. Genentech, Inc. Company Details
    Table 46. Genentech, Inc. Business Overview
    Table 47. Genentech, Inc. Acquired Hemophilia Treatment Product
    Table 48. Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 49. Genentech, Inc. Recent Development
    Table 50. Novo Nordisk A/S Company Details
    Table 51. Novo Nordisk A/S Business Overview
    Table 52. Novo Nordisk A/S Acquired Hemophilia Treatment Product
    Table 53. Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 54. Novo Nordisk A/S Recent Development
    Table 55. Ferring B.V. Company Details
    Table 56. Ferring B.V. Business Overview
    Table 57. Ferring B.V. Acquired Hemophilia Treatment Product
    Table 58. Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 59. Ferring B.V. Recent Development
    Table 60. Sanofi SA Company Details
    Table 61. Sanofi SA Business Overview
    Table 62. Sanofi SA Acquired Hemophilia Treatment Product
    Table 63. Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 64. Sanofi SA Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Acquired Hemophilia Treatment Product Picture
    Figure 2. Global Acquired Hemophilia Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Acquired Hemophilia Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Acquired Hemophilia Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Acquired Hemophilia Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Acquired Hemophilia Treatment Market Share in Global 2017-2028
    Figure 7. Acquired Hemophilia Treatment Report Years Considered
    Figure 8. Product Picture of Traditional Therapy
    Figure 9. Product Picture of Advanced Therapy
    Figure 10. Global Acquired Hemophilia Treatment Market Share by Type in 2022 & 2028
    Figure 11. Global Acquired Hemophilia Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Acquired Hemophilia Treatment Market Share by Type (2017-2028)
    Figure 13. United States Acquired Hemophilia Treatment Market Share by Type in 2022 & 2028
    Figure 14. United States Acquired Hemophilia Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Acquired Hemophilia Treatment Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Clinic
    Figure 18. Product Picture of Others
    Figure 19. Global Acquired Hemophilia Treatment Market Share by Application in 2022 & 2028
    Figure 20. Global Acquired Hemophilia Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Acquired Hemophilia Treatment Market Share by Application (2017-2028)
    Figure 22. United States Acquired Hemophilia Treatment Market Share by Application in 2022 & 2028
    Figure 23. United States Acquired Hemophilia Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Acquired Hemophilia Treatment Market Share by Application (2017-2028)
    Figure 25. North America Acquired Hemophilia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Acquired Hemophilia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Acquired Hemophilia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Acquired Hemophilia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Acquired Hemophilia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Acquired Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Baxalta, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2017-2022)
    Figure 54. Baxter Healthcare Corporation Revenue Growth Rate in Acquired Hemophilia Treatment Business (2017-2022)
    Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Acquired Hemophilia Treatment Business (2017-2022)
    Figure 56. Genentech, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2017-2022)
    Figure 57. Novo Nordisk A/S Revenue Growth Rate in Acquired Hemophilia Treatment Business (2017-2022)
    Figure 58. Ferring B.V. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2017-2022)
    Figure 59. Sanofi SA Revenue Growth Rate in Acquired Hemophilia Treatment Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Baxalta, Inc.
Baxter Healthcare Corporation
Bristol-Myers Squibb
Genentech, Inc.
Novo Nordisk A/S
Ferring B.V.
Sanofi SA
Frequently Asked Questions
Acquired Hemophilia Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acquired Hemophilia Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acquired Hemophilia Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports